Cite
HARVARD Citation
Chan, C. et al. (2023). Polo‐like kinase 4 inhibitor CFI‐400945 suppresses liver cancer through cell cycle perturbation and eliciting antitumor immunity. Hepatology. 77 (3), pp. 729-744. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Chan, C. et al. (2023). Polo‐like kinase 4 inhibitor CFI‐400945 suppresses liver cancer through cell cycle perturbation and eliciting antitumor immunity. Hepatology. 77 (3), pp. 729-744. [Online].